Cetera Advisor Networks LLC Amgen Inc Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $495,258 - $597,839	1,842 Added 1.68%	111,213 $31.6 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $150,351 - $169,614	588 Added 0.54%	109,371 $31.5 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1.42 Million - $1.76 Million	6,482 Added 6.34%	108,783 $29.2 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $1.75 Million - $2.07 Million	8,182 Added 8.69%	102,301 $22.7 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.66 Million - $2.03 Million	7,371 Added 8.5%	94,119 $22.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.16 Million - $2.74 Million	9,432 Added 12.2%	86,748 $22.8 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $2.52 Million - $2.84 Million	11,222 Added 16.98%	77,316 $17.4 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $1.47 Million - $1.63 Million	6,363 Added 10.65%	66,094 $16.1 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $483,928 - $535,351	2,207 Added 3.84%	59,731 $14.4 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $1.01 Million - $1.15 Million	-5,060 Reduced 8.09%	57,524 $12.9 Million
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $608,365 - $712,774	2,866 Added 4.8%	62,584 $13.3 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $7.94 Million - $8.81 Million	34,011 Added 132.3%	59,718 $14.6 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $231,452 - $269,719	-1,043 Reduced 3.9%	25,707 $6.4 Million
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $115,546 - $137,595	-534 Reduced 1.96%	26,750 $6.15 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $182,088 - $202,497	776 Added 2.93%	27,284 $6.93 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $71,409 - $87,629	361 Added 1.38%	26,508 $6.25 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $16,766 - $22,236	-92 Reduced 0.35%	26,147 $5.3 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $182,020 - $233,958	962 Added 3.81%	26,239 $6.32 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $44,223 - $52,989	-254 Reduced 0.99%	25,277 $4.91 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $294,725 - $345,484	1,768 Added 7.44%	25,531 $4.71 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $432,641 - $487,680	2,392 Added 11.19%	23,763 $4.51 Million
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $29,614 - $34,569	-166 Reduced 0.77%	21,371 $4.17 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $371,321 - $418,615	2,004 Added 10.26%	21,537 $4.45 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $338,409 - $380,107	-2,038 Reduced 9.45%	19,533 $3.6 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $35,919 - $41,976	212 Added 0.99%	21,571 $3.67 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $8,439 - $9,429	-50 Reduced 0.23%	21,359 $3.72 Million
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $74,611 - $85,186	446 Added 2.13%	21,409 $4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,963	20,963 $3.61 Million

Others Institutions Holding AMGN

# of Institutions

3,183

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

Vanguard Group Inc Valley Forge, PA

52.7M
Shares

$16.7 Billion
0.25% of portfolio
Black Rock Inc. New York, NY

46M
Shares

$14.6 Billion
0.33% of portfolio
State Street Corp Boston, MA

29.4M
Shares

$9.3 Billion
0.31% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$4.6 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

13.2M
Shares

$4.17 Billion
0.65% of portfolio

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account